Neurotech, Inc. is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Neurotech’s lead product (NT-501) is in clinical development for the treatment of retinal degeneration, including retinitis pigmentosa (RP), an inherited disease leading to blindness, and geographic atrophy, a serious condition associated with atrophic (dry) macular degeneration.

For more information, please visit